EG23918A - Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals - Google Patents

Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals

Info

Publication number
EG23918A
EG23918A EGNA2005000119A EG23918A EG 23918 A EG23918 A EG 23918A EG NA2005000119 A EGNA2005000119 A EG NA2005000119A EG 23918 A EG23918 A EG 23918A
Authority
EG
Egypt
Prior art keywords
regulation
specific
type
gene expression
electromagnetic signals
Prior art date
Application number
Other languages
English (en)
Inventor
Carl T Brigton
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Application granted granted Critical
Publication of EG23918A publication Critical patent/EG23918A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrotherapy Devices (AREA)
EGNA2005000119 2002-10-09 2005-04-09 Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals EG23918A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/267,708 US6919205B2 (en) 2000-02-23 2002-10-09 Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals
PCT/US2003/031793 WO2004033644A2 (fr) 2002-10-09 2003-10-07 Regulation de l'expression genique du collagene de type ii au moyen de signaux electriques et electromagnetiques specifiques et selectifs

Publications (1)

Publication Number Publication Date
EG23918A true EG23918A (en) 2007-12-30

Family

ID=32068429

Family Applications (1)

Application Number Title Priority Date Filing Date
EGNA2005000119 EG23918A (en) 2002-10-09 2005-04-09 Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals

Country Status (16)

Country Link
US (1) US6919205B2 (fr)
EP (1) EP1575475B1 (fr)
JP (1) JP2006501853A (fr)
KR (1) KR20050056233A (fr)
CN (1) CN1703184A (fr)
AU (1) AU2003279184A1 (fr)
BR (1) BR0315241A (fr)
CA (1) CA2501554C (fr)
CR (1) CR7789A (fr)
EG (1) EG23918A (fr)
ES (1) ES2593307T3 (fr)
MX (1) MXPA05003785A (fr)
NO (1) NO20052254L (fr)
NZ (1) NZ539833A (fr)
WO (1) WO2004033644A2 (fr)
ZA (1) ZA200503422B (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
JP4175662B2 (ja) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ．ヴイ． 電気的筋肉制御装置
US7167748B2 (en) 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
US8321013B2 (en) 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
WO2006073671A1 (fr) 2004-12-09 2006-07-13 Impulse Dynamics Nv Modification de l'activite proteique
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US7465566B2 (en) * 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US7429471B2 (en) * 2000-02-23 2008-09-30 The Trustees Of The University Of Pennsylvania Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
US7374916B2 (en) 2000-02-23 2008-05-20 The Trustees Of The University Of Pennsylvania Regulation of aggrecan gene expression using specific and selective electrical and electromagnetic signals
US8313908B2 (en) 2000-02-23 2012-11-20 The Trustees Of The University Of Pennsylvania Regulation of stem cell gene production with specific and selective electric and electromagnetic fields
US7465546B2 (en) * 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of transforming growth factor-beta (TGF-β) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
US7022506B2 (en) * 2000-02-23 2006-04-04 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
US7981611B2 (en) * 2000-02-23 2011-07-19 The Trustees Of The University Of Pennsylvania Regulation of fibroblastic growth factor-2 (FGF-2) gene expression in living cells with the application of specific and selective electric and electromagnetic fields
US7840262B2 (en) 2003-03-10 2010-11-23 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
GB2400316A (en) * 2003-04-10 2004-10-13 Richard Markoll Electromagnetic stimulation in patients with osteoporosis
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US20110112352A1 (en) * 2003-12-05 2011-05-12 Pilla Arthur A Apparatus and method for electromagnetic treatment
US9440089B2 (en) 2003-12-05 2016-09-13 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological injury or condition caused by a stroke
US9415233B2 (en) 2003-12-05 2016-08-16 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological pain
US8961385B2 (en) 2003-12-05 2015-02-24 Ivivi Health Sciences, Llc Devices and method for treatment of degenerative joint diseases with electromagnetic fields
US9433797B2 (en) 2003-12-05 2016-09-06 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurodegenerative conditions
US20130218235A9 (en) * 2005-03-07 2013-08-22 Arthur A. Pilla Excessive fibrous capsule formation and capsular contracture apparatus and method for using same
US7744524B2 (en) * 2003-12-05 2010-06-29 Ivivi Health Sciences, Llc Apparatus and method for electromagnetic treatment of plant, animal, and human tissue, organs, cells, and molecules
US9656096B2 (en) 2003-12-05 2017-05-23 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic enhancement of biochemical signaling pathways for therapeutics and prophylaxis in plants, animals and humans
US10350428B2 (en) 2014-11-04 2019-07-16 Endonovo Therapetics, Inc. Method and apparatus for electromagnetic treatment of living systems
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
BRPI0509444A (pt) 2004-04-19 2007-09-04 Ivivi Technologies Inc método para o tratamento eletromagnético de tecidos e células vivos através da intensificação da angiogênese e da neovascularização, aparelho de tratamento eletromagnético e dispositivo gerador de sinais eletromagnéticos
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) * 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US7279110B2 (en) * 2004-12-27 2007-10-09 Asml Holding N.V. Method and apparatus for creating a phase step in mirrors used in spatial light modulator arrays
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US7840272B2 (en) * 2005-06-03 2010-11-23 Medrelief Inc. Methods for modulating osteochondral development using bioelectrical stimulation
US7774057B2 (en) * 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
US20070190028A1 (en) * 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
US20090018613A1 (en) * 2006-08-02 2009-01-15 Genestim, Llc Regulation of vascular endothelial growth factor (vegf) gene expression in tissue via the application of electric and/or electromagnetic fields
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
CN101891803B (zh) * 2010-07-15 2012-09-05 北京大学第三医院 一种软骨亲和多肽序列、其筛选方法及应用
CA2813036A1 (fr) 2010-10-01 2012-04-05 Ivivi Health Sciences, Llc Methode et appareil pour le traitement electromagnetique d'une blessure cerebrale et neuronale de la tete chez des humains et des animaux
US8795147B1 (en) 2010-10-07 2014-08-05 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Modifying the genetic regulation of bone and cartilage cells and associated tissue by EMF stimulation fields and uses thereof
US9896681B2 (en) 2010-10-07 2018-02-20 The United States Of America As Represented By The National Aeronautics And Space Administration Genetic regulation of bone and cells by electromagnetic stimulation fields and uses thereof
US8343027B1 (en) 2012-01-30 2013-01-01 Ivivi Health Sciences, Llc Methods and devices for providing electromagnetic treatment in the presence of a metal-containing implant
WO2015161063A1 (fr) 2014-04-16 2015-10-22 Iviv Health Sciences, Llc Applicateur de champ électromagnétique pulsé à deux parties d'application d'énergie thérapeutique
WO2018008023A1 (fr) * 2016-07-07 2018-01-11 Venus Concept Ltd. Appareil à usage esthétique utile pour accroître la régénération de la peau et procédés associés
WO2018089795A1 (fr) 2016-11-10 2018-05-17 Qoravita LLC Système et procédé d'application d'un champ magnétique à basse fréquence à des tissus biologiques
CN110604098B (zh) * 2019-09-23 2021-09-07 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 一种类风湿关节炎合并间质性肺病动物模型的构建方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4509520A (en) 1982-02-22 1985-04-09 Biolectron, Inc. Electrical stimulating apparatus
US5269746A (en) 1982-12-20 1993-12-14 Jacobson Jerry I Therapeutic treatment of mammals for epilepsy and Parkinson's disease
US4535775A (en) 1983-02-10 1985-08-20 Biolectron, Inc. Method for treatment of non-union bone fractures by non-invasive electrical stimulation
IT1159024B (it) 1983-06-02 1987-02-25 Ruggero Cadossi Metodo e dispositivo per il trattamento di tessuti e cellule viventi mediante campi elettromagnetici pulsanti
US4600010A (en) 1984-10-04 1986-07-15 Biolectron, Inc. Electric stimulator and test instrument therefor
US5014699A (en) 1986-05-23 1991-05-14 Trustees Of The University Of Pennsylvania Electromagnetic method and apparatus for healing living tissue
US5038797A (en) 1990-02-20 1991-08-13 Romaine, Incorporated Electrical stimulation treatment device and method of use
US5273033A (en) 1991-09-19 1993-12-28 Murray Electronics Associates Limited Partnership Electrical stimulation for treatment of osteoarthritis
US5338286A (en) 1992-12-08 1994-08-16 Electro-Biology, Inc. Electromagnetic bioresponse by selective spectral suppression in pulsed field stimulation
US5374283A (en) 1993-12-01 1994-12-20 Flick; A. Bart Electrical therapeutic apparatus
US6261221B1 (en) 1996-11-01 2001-07-17 Amei Technologies Inc. Flexible coil pulsed electromagnetic field (PEMF) stimulation therapy system
US6132362A (en) 1996-11-01 2000-10-17 Amei Technologies, Inc. Pulsed electromagnetic field (PEMF) stimulation therapy system with bi-phasic coil
US5743844A (en) 1996-11-01 1998-04-28 Amei Technologies, Inc. High efficiency pulsed electromagnetic field (PEMF) stimulation therapy method and system
US5968527A (en) 1997-02-27 1999-10-19 Catholic University Of America, The Protection of living systems from the adverse effects of stress
US6083149A (en) 1997-10-22 2000-07-04 Emf Therapeutics, Inc. Magnetic field device and method for inhibiting angiogenesis and retarding growth rates of tumors in mammals
US6186940B1 (en) 1998-05-18 2001-02-13 Robert N. Kirschbaum Energized trace elements
US7465566B2 (en) 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US6485963B1 (en) 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof

Also Published As

Publication number Publication date
BR0315241A (pt) 2005-08-23
US20040073260A1 (en) 2004-04-15
EP1575475B1 (fr) 2016-06-29
CN1703184A (zh) 2005-11-30
AU2003279184A1 (en) 2004-05-04
EP1575475A2 (fr) 2005-09-21
US6919205B2 (en) 2005-07-19
WO2004033644A3 (fr) 2004-09-23
MXPA05003785A (es) 2005-09-20
NZ539833A (en) 2008-08-29
CA2501554A1 (fr) 2004-04-22
EP1575475A4 (fr) 2007-10-10
KR20050056233A (ko) 2005-06-14
ZA200503422B (en) 2006-12-27
CA2501554C (fr) 2014-08-05
NO20052254L (no) 2005-07-04
CR7789A (es) 2005-10-05
WO2004033644A2 (fr) 2004-04-22
NO20052254D0 (no) 2005-05-06
ES2593307T3 (es) 2016-12-07
JP2006501853A (ja) 2006-01-19

Similar Documents

Publication Publication Date Title
EG23918A (en) Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals
AU2001241737A1 (en) Regulation of genes via application of specific and selective electrical and electromagnetic signals
EG24170A (en) Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic
AU2003293132A8 (en) Integration of gene expression data and non-gene data
AU2003295801A8 (en) Modulation of hif1alpha and hif2alpha expression
ZA200503041B (en) Resolution of aggrecan gene expression using specific and selective electrical and electromagnetic signals
ZA200407942B (en) Methods of including terminal differentiation
EP1474445A4 (fr) Glyco-isoformes d'adiponectine, et utilisations correspondantes
MX223252B (en) Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase
IL157562A0 (en) NEW ELONGASE GENE AND PRODUCTION OF Delta9-POLYUNSATURATED FATTY ACIDS
AU2002327607A8 (en) Human genes and gene expression products isolated from human prostate
AU2003239579A1 (en) Antisense modulation of vegf-c expression
GB9927191D0 (en) Methods and means for regulation of gene expression
AU2003225161A1 (en) Enhancement of human epidermal melanogenesis
GB0006159D0 (en) Predicting future behaviour of an individual
AU2002365202A8 (en) Synthetic genes for malarial proteins and methods of use
AU2003257966A8 (en) Antisense modulation of lar expression
GB0015119D0 (en) Methods and means for regulation of gene expression
AU2001289104A1 (en) Methods of producing cells and animals comprising targeted gene modifications
GB0324530D0 (en) An edible transfer tattoo and method of manufacture therefor
AU2003230301A1 (en) Antisense modulation of dyrk4 expression
AU2003235589A8 (en) Modified fatty acid hydroxylase protein and genes
GB0117964D0 (en) Control of gene expression
GB2409680B (en) Methods and medicaments for controlling proliferation of cells
AU2003284382A8 (en) Methods and vectors for controlling gene expression